Mandate

Vinge advises SBB on its offer for Hemfosa

November 15, 2019 Capital Markets and Public M&A

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.

The total offer consideration consists of a combination of cash and SBB shares. At announcement, the total offer value for all Hemfosa shares is approximately SEK 23.5 billion. SBB is a major Nordic social infrastructure property company with a property portfolio with a market value of SEK 30.8 billion as of 30 September 2019. SBB’s Class B and Class D common shares are listed in Nasdaq Stockholm, Large Cap.

SBB has retained Vinge as legal advisor. The Vinge team mainly consist of Jesper Schönbeck, Erik Sjöman, Rikard Lindahl, Malte Hedlund, Boris Kotur and Clara Sohlberg, and Albert Wållgren, Ludvig Wettergren and Axel Jansson (on finance matters), Trine Osen Bergqvist and Johan Wahlbom (on competition matters) and Maria Schultzberg and Victor Ericsson (on tax matters).

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025